Affiliation: New Jersey
- Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysisAnushua Sinha
Department of Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey New Jersey Medical School, Newark NJ 07101, USA
Lancet 369:389-96. 2007..Our aim was to incorporate these data into an economic analysis of pneumococcal vaccination of infants in countries eligible for financial support from the Global Alliance for Vaccines & Immunization (GAVI)...
- Economic burden of acute lower respiratory tract infection in South African childrenAnushua Sinha
Department of Preventive Medicine and Community Health, New Jersey Medical School, Newark, USA
Paediatr Int Child Health 32:65-73. 2012..Acute lower respiratory tract infections (ALRTI) are a leading cause of childhood mortality, but there are few data on disease costs in developing countries...
- Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysisAnushua Sinha
University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 07090, United States of America
Rev Panam Salud Publica 24:304-13. 2008..Our aim was to incorporate vaccine, demographic, epidemiologic, and cost data into an economic analysis of pneumococcal vaccination of infants in Latin America and the Caribbean...
- Costs and consequences associated with newer medications for glycemic control in type 2 diabetesAnushua Sinha
Center for Healthcare KnowledgeManagement, Veterans Health Administration New Jersey, East Orange, New Jersey, USA
Diabetes Care 33:695-700. 2010..We undertook a health economic analysis to better understand the value of adding two newer medications (exenatide and sitagliptin) as second-line therapy to glycemic control strategies for patients with new-onset diabetes...
- Disappearance of vaccine-type invasive pneumococcal disease and emergence of serotype 19A in a minority population with a high prevalence of human immunodeficiency virus and low childhood immunization ratesAzadeh Tasslimi
Department of Preventive Medicine and Community Health, New Jersey Medical School UMDNJ, MSB F594, Newark, NJ 07103, USA
Clin Vaccine Immunol 16:1256-9. 2009..We observed near-elimination of vaccine-type IPD. Substantial disease remains due to non-vaccine-type pneumococci, highlighting the need to increase pneumococcal immunization among HIV-infected adults...
- Cost effectiveness of child pneumococcal conjugate vaccination in GAVI-eligible countriesAzadeh Tasslimi
Department of Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey New Jersey Medical School, 185 South Orange Avenue, MSB F506, Newark, NJ 07101, USA
Int Health 3:259-69. 2011..The current analysis supports PCV introduction in GAVI-eligible countries owing to its potential to avert substantial numbers of deaths at relatively low incremental costs. ..
- Invasive pneumococcal disease in an underimmunized, high HIV prevalence populationAzadeh Tasslimi
UMDNJ School of Public Health, 65 Bergen Street, Newark, NJ 07107, USA
J Infect 56:99-102. 2008..To describe the epidemiology of invasive pneumococcal disease (IPD) in a predominantly minority population with low childhood immunization rates and high HIV prevalence, during the early childhood pneumococcal vaccine (PCV7) era...
- Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetesMangala Rajan
Center for Healthcare Knowledge Management, Veterans Health Administration New Jersey, East Orange, NJ, USA
Qual Life Res 22:53-64. 2013..We used within-method and across-method comparisons and estimated disutilities associated with increasing chronic kidney disease (CKD) severity...
- CONSEQUENCES OF GROUP B STREPTOCOCCAL PROPHYLAXISAnushua Sinha; Fiscal Year: 2004..This application for a K23 award combines coursework, a research plan, and personal mentoring to train Anushua Sinha M.D., M.P.H. for independence as a clinical investigator. Dr...